| ID | 69654 |
| Title Alternative | EGFRとMETを標的とする二重特異性抗体であるアミバンタマブのALK融合遺伝子陽性非小細胞肺癌細胞株に対する有効性
|
| FullText URL | |
| Author |
NISHI, Tatsuya
Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
|
| Note | 岡山大学審査学位論文
Nishi T, Morita A, Hara N, Makimoto G, Ninomiya K, Fujii M, Rai K, Ohashi K, Hotta K, Tabata M, Togashi Y, Maeda Y, Ichihara E. Efficacy of amivantamab, a bi-specific antibody targeting EGFR and MET, in ALK-rearranged non-small-cell lung cancer cell lines. Lung Cancer. 2025 Mar;201:108415. doi: 10.1016/j.lungcan.2025.108415.
|
| Published Date | 2025-09-25
|
| Content Type |
Thesis or Dissertation
|
| Grant Number | 甲第7347号
|
| Granted Date | 2025-09-25
|
| Thesis Type |
Doctor of Philosophy in Medical Science
|
| Grantor | 岡山大学
|
| Thesis FullText |
Thesis or Dissertation (See FullText URL)
|
| Related Url | isVersionOf https://doi.org/10.1016/j.lungcan.2025.108415
|
| language |
English
|
| File Version | ETD
|
| Grant ID | 15301甲第7347号
|
| PubMed ID | |
| Copyright Holders | © 2025 The Author(s).
|
| DOI | |
| License | http://creativecommons.org/licenses/by-nc-nd/4.0/
|
